Clinical Pharmacology and Toxicology
Learning Objectives
By the end of this chapter, you should be able to:
- Classify adverse drug reactions (ADRs) using the Type A–F system and give an example of each.
- Distinguish pharmacokinetic from pharmacodynamic drug interactions and predict their clinical consequences.
- List the major cytochrome P450 enzyme interactions (inducers, inhibitors) and their exam-favorite drug pairs.
- Recognize the clinical presentation of the most commonly tested poisonings (paracetamol, opioids, organophosphates, iron, digoxin, benzodiazepines).
- Match each poison to its specific antidote and explain the antidote's mechanism.
- Apply a structured approach (ABC → decontamination → antidote → supportive care) to any toxicological emergency.
Quick Answer
Clinical pharmacology studies how drugs behave and are used safely in patients; toxicology studies how chemicals — including drugs themselves in overdose — cause harm. Together they explain why a normal dose of one drug can become dangerous when combined with another (drug interaction), why some patients react badly to a drug that helps everyone else (adverse drug reaction), and how to reverse poisoning with a specific antidote once you know the culprit. This matters clinically because ADRs are a leading cause of hospital admission, drug interactions are largely preventable with knowledge of enzyme pathways, and prompt antidote use (like N-acetylcysteine for paracetamol or naloxone for opioids) can be the difference between full recovery and death.
Adverse Drug Reactions (ADRs)
Definition
An adverse drug reaction is any harmful, unintended response to a drug given at a normal therapeutic dose.
The Rawlins–Thompson classification (Type A–F)
| Type | Name | Mechanism | Example |
|---|---|---|---|
| A | Augmented | Exaggeration of the drug's known pharmacological action; dose-dependent, predictable | Hypoglycemia from insulin, bleeding from warfarin |
| B | Bizarre | Not related to the known pharmacology; unpredictable, often immunologic | Anaphylaxis to penicillin, Stevens-Johnson syndrome from carbamazepine |
| C | Chronic | Related to cumulative dose over long-term use | Adrenal suppression from chronic corticosteroids |
| D | Delayed | Appears months to years after exposure | Teratogenicity, secondary malignancy after chemotherapy |
| E | End-of-use | Occurs on drug withdrawal | Rebound hypertension after abrupt clonidine withdrawal, opioid withdrawal syndrome |
| F | Failure | Unexpected failure of therapy, often due to interaction or resistance | Oral contraceptive failure with rifampicin co-administration |
Explanation
Type A reactions make up roughly 80% of clinically encountered ADRs and are usually manageable by dose reduction — think of them as "too much of a good thing." Type B reactions are the dangerous unpredictable ones: they don't correlate with dose, so a tiny exposure can still trigger a severe reaction, and they are the classic exam trap for anaphylaxis and severe cutaneous reactions.
Why It Matters
Recognizing which type of ADR you're dealing with changes your response. A Type A reaction usually means "reduce the dose and continue"; a Type B reaction usually means "stop the drug immediately and never rechallenge."
Common Misunderstanding
Students often assume all ADRs are allergic reactions. Only Type B reactions are typically immune-mediated; Type A reactions are simply an extension of the drug's normal pharmacology (e.g., a beta-blocker causing bradycardia is not an "allergy," it's the drug doing exactly what it's designed to do, just too much).
Drug Interactions
Definition
A drug interaction occurs when the effect of one drug is altered by the presence of another drug, food, or substance.
Pharmacokinetic interactions
These alter how much drug reaches its site of action — absorption, distribution, metabolism, or excretion.
- Absorption: Antacids (calcium, magnesium, aluminum) chelate tetracyclines and fluoroquinolones, reducing their absorption — always separate dosing by 2 hours.
- Metabolism (the highest-yield category for exams): The cytochrome P450 system, mainly in the liver, is the battlefield here.
- Enzyme inducers speed up metabolism of other drugs, lowering their levels: rifampicin, carbamazepine, phenytoin, phenobarbital, chronic alcohol use ("the classic inducers"). This is why rifampicin can cause oral contraceptive failure.
- Enzyme inhibitors slow metabolism, raising drug levels toward toxicity: ciprofloxacin, erythromycin/clarithromycin, ketoconazole, cimetidine, ritonavir, grapefruit juice. This is why ciprofloxacin plus warfarin increases bleeding risk — ciprofloxacin inhibits CYP1A2/CYP3A4, warfarin accumulates, and INR climbs.
- Excretion: Probenecid competes with penicillin for renal tubular secretion, prolonging penicillin's action (a mechanism once used deliberately to make penicillin last longer).
Pharmacodynamic interactions
These occur when two drugs act on the same physiological system without changing each other's blood levels.
- Synergism/additive toxicity: Combining two QT-prolonging drugs (e.g., a macrolide with an antipsychotic) additively increases torsades de pointes risk.
- Antagonism: Naloxone displaces opioids from mu receptors without altering their metabolism — it is a pharmacodynamic antagonist, not a metabolic one.
Real-World Example
A patient stable on warfarin is prescribed ciprofloxacin for a urinary tract infection. Within days their INR rises sharply and they develop gum bleeding — a textbook pharmacokinetic interaction that is entirely predictable and preventable with INR monitoring or choosing a non-interacting antibiotic.
Why It Matters
Most serious drug interactions are foreseeable if you know a short list of enzyme inducers and inhibitors. This is one of the highest-yield, most testable areas in clinical pharmacology because the logic is reusable across hundreds of drug pairs.
Common Misunderstanding
Students often think "interaction" always means the combination is dangerous. Some interactions are therapeutic and intentional — for example, combining levodopa with carbidopa (a peripheral decarboxylase inhibitor) deliberately increases levodopa's availability to the brain while reducing peripheral side effects.
Common Poisonings and Antidotes
Definition
An antidote is a substance that specifically counteracts the toxic effect of a poison, either by neutralizing it, blocking its receptor, accelerating its elimination, or reversing its downstream effect.
The high-yield antidote table
| Poison / Overdose | Key Clinical Clue | Antidote | Mechanism |
|---|---|---|---|
| Paracetamol (acetaminophen) | Initially asymptomatic or mild nausea; day 2–3 rising liver enzymes | N-acetylcysteine (NAC) | Replenishes glutathione, which detoxifies the toxic metabolite NAPQI |
| Opioids (morphine, heroin, fentanyl) | Pinpoint pupils, respiratory depression, decreased consciousness | Naloxone | Competitive mu-opioid receptor antagonist |
| Benzodiazepines | Sedation, slurred speech, ataxia (respiration often preserved) | Flumazenil | Competitive GABA-A benzodiazepine-site antagonist |
| Organophosphates (pesticides, nerve agents) | SLUDGE symptoms (salivation, lacrimation, urination, defecation, GI distress, emesis), miosis, bradycardia | Atropine + Pralidoxime | Atropine blocks muscarinic receptors; pralidoxime reactivates inhibited acetylcholinesterase |
| Iron salts | Vomiting, hematemesis, later metabolic acidosis and hepatotoxicity | Deferoxamine | Chelates free iron for renal excretion |
| Digoxin | Nausea, visual halos/yellow-green vision, arrhythmias | Digoxin-specific antibody fragments (Digibind) | Binds free digoxin, forming an inactive complex excreted renally |
| Methanol / ethylene glycol | Metabolic acidosis with high anion and osmolar gap; visual disturbance (methanol) | Fomepizole (or ethanol) | Competitively inhibits alcohol dehydrogenase, blocking formation of toxic metabolites |
| Warfarin (excess anticoagulation) | Bleeding, elevated INR | Vitamin K (± fresh frozen plasma/PCC for severe bleeding) | Restores synthesis of clotting factors II, VII, IX, X |
| Heparin | Bleeding, elevated aPTT | Protamine sulfate | Binds and neutralizes heparin's negative charge |
| Benzylisoquinoline/anticholinergics (atropine, TCAs) | "Hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter" | Physostigmine (used cautiously) | Acetylcholinesterase inhibitor, increases available acetylcholine |
| Cyanide | Almond smell, severe lactic acidosis despite normal oxygenation | Hydroxocobalamin (or sodium nitrite + sodium thiosulfate) | Binds cyanide to form nontoxic cyanocobalamin |
| Methotrexate (folate antagonist toxicity) | Mucositis, myelosuppression | Leucovorin (folinic acid) | Bypasses the blocked enzyme, restoring folate metabolism |
Explanation
Notice the pattern: antidotes work through one of four mechanisms — neutralization (protamine binding heparin), receptor competition (naloxone at opioid receptors), metabolic pathway blockade (fomepizole blocking alcohol dehydrogenase), or replenishing a depleted resource (NAC restoring glutathione). Recognizing which mechanism applies helps you predict an antidote's side effects and monitoring needs.
Real-World Example
Paracetamol overdose is deceptively dangerous because the patient often feels almost fine for the first 24 hours while the liver is being silently damaged by the toxic metabolite NAPQI. The Rumack-Matthew nomogram plots serum paracetamol level against time since ingestion to decide whether NAC is needed — this is why timing of ingestion is always the first question asked in a suspected overdose.
Why It Matters
In a genuine toxicological emergency, giving the right antidote quickly can be lifesaving, but giving the wrong one, or giving an antidote when the diagnosis is uncertain, can cause harm (e.g., flumazenil can precipitate seizures in a patient who has co-ingested tricyclic antidepressants or is benzodiazepine-dependent).
Common Misunderstanding
Students often think an antidote "cures" the poisoning instantly. In reality, most poisoning management is still primarily supportive care (airway protection, fluids, monitoring) — the antidote is one component, not a replacement for the ABCs.
Visual Learning: Poisoning Management Pathway
Key Terms
| Term | Definition |
|---|---|
| Adverse Drug Reaction (ADR) | An unintended, harmful response to a drug at a normal therapeutic dose |
| Pharmacokinetics | What the body does to a drug: absorption, distribution, metabolism, excretion (ADME) |
| Pharmacodynamics | What the drug does to the body: mechanism and magnitude of effect |
| Enzyme induction | Increased synthesis of metabolizing enzymes (e.g., CYP450), lowering blood levels of co-administered drugs |
| Enzyme inhibition | Reduced enzyme activity, raising blood levels of co-administered drugs toward toxicity |
| Antidote | A substance that specifically counteracts a poison's toxic effect |
| Therapeutic index | The ratio between the toxic dose and the effective dose of a drug; a narrow index means small dose changes risk toxicity |
| Decontamination | Techniques (activated charcoal, gastric lavage, whole bowel irrigation) to reduce ongoing toxin absorption |
| NAPQI | The toxic metabolite of paracetamol that depletes glutathione and causes hepatocellular necrosis |
| Anion gap | A calculation used to detect metabolic acidosis caused by toxins like methanol, ethylene glycol, or salicylates |
Common Mistakes
Misconception 1: "If a drug interaction exists, the two drugs should never be prescribed together."
- Why it's wrong: Many interacting combinations are safe and even standard practice with appropriate monitoring or dose adjustment (e.g., warfarin with many antibiotics, managed with more frequent INR checks).
- Correct explanation: An interaction changes the risk-benefit calculation and monitoring plan; it does not automatically mean the combination is forbidden.
Misconception 2: "Activated charcoal works for every poisoning."
- Why it's wrong: Activated charcoal does not bind well to alcohols, iron, lithium, or strong acids/alkalis, and it is contraindicated in patients with an unprotected airway or reduced consciousness due to aspiration risk.
- Correct explanation: Decontamination strategy depends on the specific toxin and the timing since ingestion; charcoal is most useful within 1–2 hours of ingesting an adsorbable substance.
Misconception 3: "A normal paracetamol level shortly after ingestion means no treatment is needed."
- Why it's wrong: Paracetamol absorption can be delayed, and a level taken too early (before 4 hours post-ingestion) cannot be reliably plotted on the Rumack-Matthew nomogram.
- Correct explanation: Levels must be interpreted against time since ingestion using the nomogram, and if timing is unknown or ingestion was staggered, treatment thresholds are applied more cautiously.
Comparison and Connections
| Concept | Type A ADR | Type B ADR | Pharmacokinetic Interaction | Pharmacodynamic Interaction |
|---|---|---|---|---|
| Dose-dependent? | Yes | No | Indirectly (via changed blood levels) | No (acts at receptor/system level) |
| Predictable from known pharmacology? | Yes | No | Yes, if enzyme pathway is known | Yes, if mechanism of both drugs is known |
| Typical management | Reduce dose | Stop drug, avoid rechallenge | Adjust dose or monitor levels | Avoid combination or monitor effect |
| Example | Bradycardia from beta-blocker | Anaphylaxis from penicillin | Warfarin + ciprofloxacin | Two QT-prolonging drugs together |
| Overdose | Key Distinguishing Clue | Antidote |
|---|---|---|
| Opioid | Pinpoint pupils + respiratory depression | Naloxone |
| Anticholinergic | Dilated pupils, dry flushed skin, delirium | Physostigmine |
| Organophosphate | Miosis, excessive secretions (SLUDGE) | Atropine + pralidoxime |
| Benzodiazepine | Sedation with preserved respiration | Flumazenil |
Practice Questions
Recall 1: What are the six categories in the Rawlins–Thompson ADR classification? Answer guidance: Type A (Augmented), B (Bizarre), C (Chronic), D (Delayed), E (End-of-use/withdrawal), F (Failure of therapy).
Recall 2: Name the antidote for paracetamol overdose and the antidote for opioid overdose. Answer guidance: N-acetylcysteine (NAC) for paracetamol; naloxone for opioids.
Understanding 1: Explain why ciprofloxacin increases the risk of bleeding in a patient taking warfarin. Answer guidance: Ciprofloxacin inhibits hepatic CYP450 enzymes (notably CYP1A2) responsible for warfarin metabolism, causing warfarin to accumulate, raising the INR and bleeding risk — a pharmacokinetic interaction via enzyme inhibition.
Understanding 2: Why is a Type B ADR harder to predict than a Type A ADR? Answer guidance: Type A reactions are extensions of the drug's known pharmacology and are dose-related, so they can be anticipated and managed by adjusting dose. Type B reactions are often immune-mediated, unrelated to dose or known pharmacology, so they cannot be predicted from the drug's mechanism of action.
Application 1: A patient presents with pinpoint pupils, shallow breathing, and reduced consciousness after a suspected overdose. What is your immediate pharmacological intervention and why? Answer guidance: Administer naloxone — it is a competitive mu-opioid receptor antagonist that rapidly reverses respiratory depression, the immediately life-threatening feature of opioid toxicity. Airway support should be provided simultaneously.
Application 2: A child ingests an unknown quantity of iron tablets and later develops vomiting, hematemesis, and lethargy. What antidote should be considered and how does it work? Answer guidance: Deferoxamine, an iron chelator that binds free serum iron to form ferrioxamine, which is then excreted renally, reducing systemic iron toxicity.
Analysis 1: Compare the mechanisms of enzyme induction and enzyme inhibition, and explain why abruptly stopping an enzyme-inducing drug (like rifampicin) in a patient on warfarin is dangerous. Answer guidance: Enzyme induction increases synthesis of CYP450 enzymes, lowering blood levels of co-administered drugs (here, warfarin is metabolized faster, so the dose is often increased to maintain therapeutic INR). If rifampicin is stopped abruptly, enzyme activity falls back to baseline over days to weeks, but the warfarin dose remains elevated — this can cause warfarin levels to rise sharply, risking serious bleeding. This illustrates why any interacting drug's discontinuation requires re-evaluating other drug doses, not just its own.
Analysis 2: A patient with a benzodiazepine overdose also appears to have co-ingested a tricyclic antidepressant. Why would giving flumazenil be risky here, and what does this teach about antidote use in general? Answer guidance: Flumazenil reverses the GABA-A-mediated sedative effect of benzodiazepines, but if the patient has also taken a proconvulsant/cardiotoxic drug like a TCA, removing the benzodiazepine's seizure-suppressing effect can unmask life-threatening seizures or arrhythmias. This teaches that antidotes are not automatically safe — they must be selected based on the full clinical picture, not just the most obvious toxin, and sometimes withholding a "correct" antidote is the safer choice.
FAQ
Q1: What's the actual difference between clinical pharmacology and toxicology? Clinical pharmacology studies how drugs work in the body at therapeutic doses to treat disease; toxicology studies how chemicals — including the same drugs at excessive doses — cause harm. They overlap heavily because most poisonings in clinical practice involve drug overdoses, not industrial chemicals.
Q2: Why does timing matter so much in paracetamol overdose management? Because the Rumack-Matthew nomogram, which decides whether N-acetylcysteine is needed, plots serum paracetamol concentration against hours since ingestion. A level drawn too early or with an unknown ingestion time cannot be reliably interpreted, so clinicians often treat empirically if timing is uncertain.
Q3: Can two drugs interact even if neither one changes the other's blood level? Yes — this is a pharmacodynamic interaction. Both drugs can circulate at their expected concentrations but still produce an additive, synergistic, or antagonistic effect because they act on the same receptor, pathway, or organ system (e.g., two sedating drugs given together causing excessive CNS depression).
Q4: Is grapefruit juice really a clinically significant drug interaction? Yes. Grapefruit juice inhibits intestinal CYP3A4, which increases the bioavailability of drugs like certain statins and calcium channel blockers, sometimes enough to cause toxicity — it's a real, testable, and clinically documented interaction.
Q5: If naloxone reverses an opioid overdose, why do patients sometimes need repeat doses? Because naloxone's half-life (roughly 30–90 minutes) is often shorter than that of the opioid it's reversing (especially long-acting opioids like methadone or fentanyl analogs), so respiratory depression can recur once naloxone wears off — patients need monitoring, not just a single dose.
Quick Revision
- ADR types: A = Augmented (dose-related, predictable), B = Bizarre (immune, unpredictable), C = Chronic, D = Delayed, E = End-of-use/withdrawal, F = Failure of therapy.
- Pharmacokinetic interactions change drug levels (absorption, metabolism, excretion); pharmacodynamic interactions change drug effect without changing levels.
- Classic enzyme inducers: rifampicin, carbamazepine, phenytoin, phenobarbital, chronic alcohol.
- Classic enzyme inhibitors: ciprofloxacin, macrolides, azole antifungals, cimetidine, ritonavir, grapefruit juice.
- Paracetamol overdose antidote: N-acetylcysteine (replenishes glutathione to detoxify NAPQI).
- Opioid overdose antidote: Naloxone (competitive mu-receptor antagonist); watch for re-narcotization once it wears off.
- Benzodiazepine overdose antidote: Flumazenil — avoid if TCA co-ingestion or seizure risk suspected.
- Organophosphate poisoning: SLUDGE symptoms + miosis; treat with atropine (muscarinic blockade) plus pralidoxime (enzyme reactivation).
- Iron overdose antidote: Deferoxamine (chelation).
- Digoxin toxicity antidote: Digoxin-specific antibody fragments.
- Warfarin reversal: Vitamin K (± FFP/PCC for active bleeding); heparin reversal: protamine sulfate.
- Poisoning management always follows: stabilize ABCs → identify toxin → decontaminate if appropriate → give specific antidote if available → supportive care and monitoring.
Related Topics
Prerequisites
- Basic pharmacokinetics (ADME) and pharmacodynamics
- Cytochrome P450 enzyme system fundamentals
- General principles of receptor pharmacology (agonists, antagonists)
Related Topics
- Pharmacogenomics and individual variation in drug metabolism
- Emergency medicine approach to the unconscious/poisoned patient
- Hepatology (drug-induced liver injury, especially paracetamol)
Next Topics
- Special population pharmacology (pediatric, geriatric, renal/hepatic impairment dosing)
- Pharmacovigilance and post-marketing drug safety surveillance
- Principles of rational prescribing and polypharmacy management